MDM2 HIFシグナリングの調節が,高縮性心筋病における微血管機能障害を引き起こす
Puneeth Shridhar1,2, Michael S Glennon1, Soumojit Pal1
1Division of Cardiology, Department of Medicine, and Pittsburgh Heart, Lung, Blood and Vascular Medicine Institute (P.S., M.S.G., S.P., C.J.W., E.J.C., P.B., N.C.G., D.B., J.R.B.), University of Pittsburgh School of Medicine and University of Pittsburgh Medical Center, PA.
Circulation
|October 27, 2023
まとめ
ハイパートロフィック心筋病 (HCM) の微小血管機能障害は,心臓の拡大に先立つ毛細血管の成長障害から生じる. MDM2 (ネズミのダブル分2) タンパク質をターゲットにすることで,HCMマウスモデルにおける機能障害を予防します.
科学分野:
- 心血管生物学
- 分子心臓科
- 血管生物学
背景:
- 微小血管機能障害は,心筋縮性心筋病 (HCM) の心臓改造の特徴である.
- HCMの病原性はサルコメア遺伝子変異と関連しているが,マイクロ血管異常の役割は調査中である.
- この研究では,HCMにおけるマイクロ血管機能不全が,心室縮とは無関係な,異常な成長に関連した主要なイベントであるかどうかを調べます.
研究 の 目的:
- HCMにおける微小血管機能障害と心筋縮の間の時間的関係を調査する.
- HCMの微小血管機能障害の基礎にある分子メカニズムを特定する.
- 特定の分子経路をターゲットにすることで,HCMにおけるマイクロ血管機能障害を防ぐことができるかどうかを判断する.
主な方法:
- *Mybpc3*および*Myh6*変異性HCMマウスモデルにおけるマイクロ血管機能障害を追跡するために,マルチモダリティ画像を用いた.
- E3ユビキチンリガゼMDM2とHIF転写因子を中心に,タンパク質レベル,相互作用,および改変を評価するために分子方法を使用した.
- 重要な分子経路の遺伝子および薬理学的操作によって検証された発見.
主要な成果:
- HCMモデルの微血管機能不全は,発達の初期に心筋毛細血管の成長が低下し,高縮症に先行した.
- HIF1αとHIF2αの安定性の重要なレギュラーとしてMDM2 (マウリン・ダブル・ミニート2) が特定され,プロ血管新生遺伝子の発現に影響を与えました.
- MDM2の遺伝的または薬学的減少はHIFレベルを正常化し,HCMマウスの微小血管機能障害を予防しました.
結論:
- サルコメア変異は,HCM発達の初期に心筋細胞MDM2シグナリングを誘発する.
- この早期のシグナリングは,心筋微小環境の長期的な変化に寄与する.
- HIF経路のMDM2媒介の調節は,HCMに関連するマイクロ血管機能障害を予防するための潜在的な治療目標です.
関連する概念動画
Cardiomyopathy III: Hypertrophic Cardiomyopathy
16
Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
16
Cardiomyopathy II: Dilated Cardiomyopathy
11
Dilated cardiomyopathy, or DCM, is a progressive myocardial disorder characterized by ventricular chamber dilation and contractile dysfunction.EtiologyVarious factors can cause DCM, including hypertension and heavy alcohol intake, which contribute to the weakening and enlargement of the heart muscle. Viral infections, such as Coxsackievirus B, adenoviruses, and influenza, can lead to DCM by causing inflammation and damage to heart tissue. Certain chemotherapeutic agents, including daunorubicin,...
11
Regulation of Angiogenesis and Blood Supply
2.6K
Rapidly dividing tumors, embryos, and wounded tissues require more oxygen than usual, lowering the oxygen concentration in the blood. At low oxygen or hypoxic conditions, an oxygen-sensitive transcription factor called the hypoxia-inducible factor 1 or HIF1 is activated. HIF1 is a dimeric protein of alpha (ɑ) and beta (β) subunits. Under optimal oxygen conditions, HIF1β is present in the nucleus while HIF1ɑ remains in the cytosol. HIF1ɑ is hydroxylated by prolyl...
2.6K
Heart Failure II: Pathophysiology
14
Systolic Heart Failure and Compensatory MechanismsSystolic heart failure (also termed HFrEF, Heart Failure with Reduced Ejection Fraction) is the most prevalent type of heart filure. It results in a decreased volume of blood being pumped from the ventricle. The aortic arch and carotid sinuses have baroreceptors that detect reduced blood pressure, triggering the sympathetic nervous system (SNS) to release epinephrine and norepinephrine. Initially, this response aims to boost heart rate and...
14
Cardiomyopathy V: Interprofessional Care
14
Managing cardiomyopathy involves addressing underlying or precipitating causes, treating heart failure with medications, and implementing dietary changes and a balanced exercise and rest regimen.Lifestyle ModificationsCardiomyopathy patients should adopt a low-sodium diet to reduce fluid retention and manage heart failure. A personalized exercise and rest plan helps maintain physical fitness without overstraining the heart. Avoiding alcohol and tobacco is essential to prevent further damage to...
14
Cardiomyopathy IV: Restrictive Cardiomyopathy
12
Restrictive cardiomyopathy (RCM) is a rare heart muscle disease characterized by impaired ventricular filling due to stiffened ventricular walls, leading to significant diastolic dysfunction.EtiologyRestrictive cardiomyopathy can arise from both inherited and acquired diseases, many of which are systemic. It is categorized into four main types: infiltrative, storage, non-infiltrative, and endomyocardial diseases.Infiltrative diseases, such as amyloidosis, lead to RCM by depositing amyloid...
12


